Skip to main content
. Author manuscript; available in PMC: 2013 Jul 21.
Published in final edited form as: Am J Drug Alcohol Abuse. 2011 Jul 29;38(1):114–119. doi: 10.3109/00952990.2011.600398

TABLE 1.

Plasma rimonabant concentrations following a single 20 or 40 mg rimonabant dose in eight daily cannabis smokers.

Rimonabant concentration (ng/mL)
Subject Dose Time of sample
11:30 15:00 22:00
A 20 89.5 76.2 49.1
B 20 181 67.0 23.6
C 20 71.8 33.2 10.7
D 20 172 54.7 27.6
E 20 168 61.4 44.8
F 40 378 111 45.0
G 40 143 67.7 23.5
H 40 187 57.2 30.3

Note: Daily cannabis smokers were administered Δ9-tetrahydrocannabinol (THC) 20 mg orally every 4–8 hours over 8 days (120 mg THC/day for last 3 days prior to rimonabant). At 9:30 on the ninth day, five subjects received rimonabant 20 mg and three subjects received rimonabant 40 mg concurrently with the last dose of THC.

HHS Vulnerability Disclosure